Brief: Extrawell Pharmaceutical Says Hy Revenue HK$34.1 Mln
29/11/2022 13:32
Nov 29 (Reuters) - Extrawell Pharmaceutical Holdings Ltd
0858.HK :
* HY REVENUE HK$34.1 MILLION VERSUS HK$43.5 MILLION
* HY PROFIT ATTRIBUTABLE HK$45.8 MILLION VERSUS HK$88.6
MILLION
Source text for Eikon: ID:nHKSbChHTp
Further company coverage: 0858.HK
Recent news on Extrawell Pharmaceutical Holdings
See all newsBrief: Extrawell Pharmaceutical Abandons Negotiations For Possible Sale Of Convertible Bonds
Brief: Extrawell Pharmaceutical Proposes Share Consolidation Of 20 Shares Into 1 Share Of HK$0.20 Par Value
Brief: Extrawell Pharmaceutical Says Mr. Wu Xiangyun Appointed As Executive Director
Brief: Extrawell Pharmaceutical Expects FY Loss Of At Least HK$950 Million
Brief: Extrawell Pharmaceutical's Unit To Buy Back 10.06% Of Its Stake For RMB4.4 Million